https://www.epo.org/de/boards-of-appeal/decisions/w010021eu1
W 0021/01 (Gingipain/MAX PLANCK) vom 24.05.2002
max planckw002101gingipain
https://www.pharmaceutical-technology.com/data-insights/quince-therapeutics-files-patent-for-inhibiting-the-lysine-gingipain-protease-from-porphyromonas-gingivalis/
Quince Therapeutics Inc: Patent for Inhibiting Lysine Gingipain Protease
Aug 21, 2023 - Discover a groundbreaking compound that inhibits the gingipain protease, offering potential treatment for Alzheimer's disease and other brain disorders. Learn...
quince therapeutics incpatentinhibitinglysinegingipain